Generic drugmakers' deals with US DOJ complicate Humana bellwether case
As Humana moves toward the first trial in massive generic drug price-fixing litigation, deals between the US Department Justice and drugmakers to resolve criminal charges have raised questions about how limited...To view the full article, register now.
Already a subscriber? Click here to view full article